PF-Atlas › Clinical Trials › NCT06918288
Post-extubation Nasal Humidified High-flow Oxygen Versus Non-invasive Positive Pressure Ventilation
High flow nasal canula · Phase 2
Registry ID
NCT06918288
Phase
Phase 2
Status
Active, not recruiting
Drug / intervention
High flow nasal canula
Sponsor
Benha University
Start
2025-03-01
Enrollment
200
Locations
1
About this trial
Acute hypercapnic respiratory failure is characterized by elevated arterial carbon dioxide levels and commonly occurs in patients with chronic respiratory diseases. Patients with type II respiratory failure who experience difficult weaning from invasive mechanical ventilation are at increased risk of post-extubation respiratory failure and reintubation. This randomized clinical trial compared high-flow nasal cannula (HFNC) with non-invasive ventilation (NIV) as respiratory support immediately after extubation in patients aged over 50 years with type II respiratory failure and difficult weaning. The primary objective was to compare reintubation rates at 72 hours and 7 days after extubation.
Explore related
Medical disclaimer. This page summarizes public trial data for NCT06918288 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.